These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18684281)

  • 21. Shocks, personality, and anxiety in patients with an implantable defibrillator.
    Van den Broek KC; Nyklícek I; Van der Voort PH; Alings M; Denollet J
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):850-7. PubMed ID: 18684282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gender differences in anxiety and concerns about the cardioverter defibrillator.
    Spindler H; Johansen JB; Andersen K; Mortensen P; Pedersen SS
    Pacing Clin Electrophysiol; 2009 May; 32(5):614-21. PubMed ID: 19422582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time to resumption of driving after implantation of an automatic defibrillator (from the Dual chamber and VVI Implantable Defibrillator [DAVID] trial).
    Baessler C; Murphy S; Gebhardt L; Tso T; Ellenbogen K; Leman R;
    Am J Cardiol; 2005 Mar; 95(5):665-6. PubMed ID: 15721116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Driving behaviors in patients with head and neck cancer during and after cancer treatment: a preliminary report.
    Yuen HK; Gillespie MB; Day TA; Morgan L; Burik JK
    Head Neck; 2007 Jul; 29(7):675-81. PubMed ID: 17274048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of anxiety, depression and quality of life between device shock and nonshock groups in implantable cardioverter defibrillator recipients.
    Jacq F; Foulldrin G; Savouré A; Anselme F; Baguelin-Pinaud A; Cribier A; Thibaut F
    Gen Hosp Psychiatry; 2009; 31(3):266-73. PubMed ID: 19410106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implantable cardioverter defibrillators and their role in heart failure progression.
    Cevik C; Perez-Verdia A; Nugent K
    Europace; 2009 Jun; 11(6):710-5. PubMed ID: 19357142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey.
    Marinskis G; van Erven L;
    Europace; 2010 Aug; 12(8):1176-7. PubMed ID: 20663788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cessation of driving and unsafe motor vehicle operation by dementia patients.
    Gilley DW; Wilson RS; Bennett DA; Stebbins GT; Bernard BA; Whalen ME; Fox JH
    Arch Intern Med; 1991 May; 151(5):941-6. PubMed ID: 2025142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators.
    ; Vijgen J; Botto G; Camm J; Hoijer CJ; Jung W; Le Heuzey JY; Lubinski A; Norekvål TM; Santomauro M; Schalij M; Schmid JP; Vardas P
    Europace; 2009 Aug; 11(8):1097-107. PubMed ID: 19525498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alert tones are frequently inaudible among patients with implantable cardioverter-defibrillators.
    Simons EC; Feigenblum DY; Nemirovsky D; Simons GR
    Pacing Clin Electrophysiol; 2009 Oct; 32(10):1272-5. PubMed ID: 19691679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disparities in preferences for receiving support and education among patients with implantable cardioverter defibrillators.
    Serber ER; Finch NJ; Leman RB; Sturdivant LJ; Barnes T; Clarke E; Garry J; Gold MR
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):383-90. PubMed ID: 19272070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
    Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
    Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of cancelled shock therapy and relationship to shock delivery in recipients of implantable cardioverter-defibrillators assessed by remote monitoring.
    Varma N; Johnson MA
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S42-6. PubMed ID: 19250110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Amphetamine doping in leisure-time mountain climbing at a medium altitude in the Alps].
    Röggla G; Röggla M; Zeiner A; Röggla H; Deusch E; Wagner A; Hibler A; Haber P; Laggner AN
    Schweiz Z Sportmed; 1993 Sep; 41(3):103-5. PubMed ID: 8211079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock.
    Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM
    J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low referral rate for prophylactic implantation of cardioverter-defibrillators in a tertiary care medical center.
    Bradfield J; Warner A; Bersohn MM
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S194-7. PubMed ID: 19250092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ESC Study Group of Sports Cardiology: recommendations for participation in leisure-time physical activity and competitive sports for patients with ischaemic heart disease.
    ; Börjesson M; Assanelli D; Carré F; Dugmore D; Panhuyzen-Goedkoop NM; Seiler C; Senden J; Solberg EE
    Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):137-49. PubMed ID: 16575266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems.
    Biffi M; Ziacchi M; Bertini M; Sangiorgi D; Corsini D; Martignani C; Diemberger I; Boriani G
    Europace; 2008 Nov; 10(11):1288-95. PubMed ID: 18772164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.